Cargando…

MEASURING COGNITIVE FUNCTION IN MDD: EMERGING ASSESSMENT TOOLS

Cognitive impairment is emerging as an important therapeutic target in patients with psychiatric illnesses, including major depressive disorder (MDD). The objective of this general overview is to briefly review the evidence for cognitive impairment in MDD and to summarize a representative sample of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Manuela, Mahon, Katie, Burdick, Katherine E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407945/ https://www.ncbi.nlm.nih.gov/pubmed/25421437 http://dx.doi.org/10.1002/da.22297

Ejemplares similares

The emergence of psychoanalytical electrochemistry: the translation of MDD biomarker discovery to diagnosis with electrochemical sensing
por: Nadar, Priyanka M., et al.
Publicado: (2022)

Why is Diagnosing MDD Challenging?
Publicado: (2016)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Cognitive behavioral therapy increases amygdala connectivity with the cognitive control network in both MDD and PTSD()
por: Shou, Haochang, et al.
Publicado: (2017)

POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDD
por: Prenoveau, Jason, et al.
Publicado: (2013)

From MDD concepts to experiments and illustrations
por: Babau, Jean-Philippe, et al.
Publicado: (2006)

The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
por: Koopowitz, Sheri‐Michelle, et al.
Publicado: (2021)

Improvements in mood symptoms, cognitive symptoms and functioning in outpatients with mdd in greece treated with vortioxetine: A patient-rated evaluation
por: Galanopoulos, A., et al.
Publicado: (2021)

Functional connectivity of the amygdala and subgenual cingulate during cognitive reappraisal of emotions in children with MDD history is associated with rumination
por: Murphy, Eric R., et al.
Publicado: (2015)

Stratification of MDD and GAD patients by resting state brain connectivity predicts cognitive bias
por: Bijsterbosch, Janine D., et al.
Publicado: (2018)

Comparison of Electroencephalography (EEG) Coherence between Major Depressive Disorder (MDD) without Comorbidity and MDD Comorbid with Internet Gaming Disorder
por: Youh, Joohyung, et al.
Publicado: (2017)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
por: Cuomo, Alessandro, et al.
Publicado: (2020)

Pharmacogenomics of MDD as a Developing Field: Challenges and Opportunities
por: Baune, B.
Publicado: (2022)

Enhanced Functional Connectivity Within Executive Function Network in Remitted or Partially Remitted MDD Patients
por: Wang, Yuchen, et al.
Publicado: (2021)

Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study
por: Matcham, Faith, et al.
Publicado: (2022)

Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
por: Alvarez-Mon, Miguel A., et al.
Publicado: (2021)

Early improvement of painful symptoms in MDD: is there an association in achieving remission?
por: Bär, Karl-Jürgen
Publicado: (2007)

Relationship of Mean Platelet Volume To MDD: A Retrospective Study
Publicado: (2017)

The change of gut microbiota in MDD patients under SSRIs treatment
por: Shen, Yang, et al.
Publicado: (2021)

PTSD and comorbid MDD is associated with activation of the right frontoparietal network
por: Koopowitz, Sheri-Michelle, et al.
Publicado: (2023)

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021)

PHQ-8 Days: a measurement option for DSM-5 Major Depressive Disorder (MDD) severity
por: Dhingra, Satvinder S, et al.
Publicado: (2011)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

How does IL-6 change after combined treatment in MDD patients? A systematic review
por: Lombardi, Aurora Leontina, et al.
Publicado: (2022)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
por: Pieters, T., et al.
Publicado: (2022)

Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD
por: Li, Gaizhi, et al.
Publicado: (2018)

White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
por: Breit, S., et al.
Publicado: (2022)

ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing
por: Schmaal, Lianne, et al.
Publicado: (2020)

The process of major depressive disorder (MDD) in women referred to the health centers
por: Rahmati-Khameneh, Souraj, et al.
Publicado: (2011)

Patient attitudes toward and goals for MDD treatment: a survey study
por: McNaughton, Emily C, et al.
Publicado: (2019)

An Examination of Psychomotor Disturbance in Current and Remitted MDD: An RDoC Study
por: Shankman, Stewart A., et al.
Publicado: (2020)

The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
por: Waters, Kristin
Publicado: (2022)

Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): Recruitment, retention, and data availability in a longitudinal remote measurement study
por: Matcham, F., et al.
Publicado: (2022)

Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD)
por: Montano, C Brendan, et al.
Publicado: (2022)

PS83. Impact of Vortioxetine on Functional Capacity in MDD Patients with Subjective Cognitive Dysfunction: A Post-hoc Analysis of the University of California San Diego Performance-Based Skills Assessment
por: Jacobson, William, et al.
Publicado: (2016)

A survey of five antidepressant properties influencing clinician’s treatment choices in MDD
por: Papakostas, George I, et al.
Publicado: (2007)

Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review
por: Salloum, Naji C., et al.
Publicado: (2020)

Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays
por: Mulvey, Bernard, et al.
Publicado: (2021)

PS236. A multi-centre, multi-country, cross-sectional study to assess and describe cognitive dysfunction in Asian patients with Major Depressive Disorder (MDD)
por: Srisurapanont, Manit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pnjn4aj2mhfo0gs22qb3q9i18r